NEW YORK, July 7 - The Indiana Proteomics Consortium today announced that it has officially changed its name to Inproteo - a name chosen to emphasize the commercial goals of the effort, consortium officials said today.
"The new name suggests where we are and what we do," said John Hurrell, Inproteo's president, in a statement. "It also implies that we are a commercial venture - our research is meant to have an economic impact."
The consortium was founded in 2002 as a partnership between Indiana University, Purdue University, and Eli Lilly. Research conducted under the auspices of Inproteo will be commercialized through the creation of new companies, joint ventures, or licensing partnerships.
Inproteo said it has filed 19 patents within its first year.
Additional information on Inproteo is available here.